Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Angiopoietin-1 (Ang1) is an essential molecule for blood vessel formation; however, little is known about the structure-function relationships of Ang1 with its receptor, Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2'). In this study, we generated several Ang1 and angiopoietin-2 (Ang2) variants to define the role of the superclustering and oligomerization domains of the Ang1 protein. Then we analyzed the molecular structure of the variants with SDS-PAGE and rotary metal-shadowing transmission electron microscopy (RMSTEM) and determined the effects of these variants on the binding and activation of Tie2. Ang1 exists as heterogeneous multimers with basic trimeric, tetrameric, and pentameric oligomers, whereas Ang2 exists as trimeric, tetrameric, and pentameric oligomers. The variant Ang1C265S, consisting of trimers, tetramers, and pentamers without multimeric forms of Ang1, yielded less Tie2 activation than did Ang1, whereas monomeric Ang1 (Ang1/FD), dimeric Ang1 variants (Ang1D2, and Ang1D3), and dimeric and trimeric Ang1 variant (Ang1D1) dramatically lost their ability to bind and activate Tie2. An Ang1 protein in which two cysteines (amino acids 41 and 54) were replaced with serines (Ang1C41S/C54S) formed mostly dimers and trimers that were not able to bind and activate Tie2. In addition, improper creation of a new cysteine in Ang2 (Ang2S263C) dramatically induced Ang2 aggregation without activating Tie2. In conclusion, proper oligomerization of Ang1 having at least four subunits by the intermolecular disulfide linkage involving cysteines 41 and 54 is critical for Tie2 binding and activation. Thus, our data shed a light on the structure-function relationships of Ang1 with Tie2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The weaker TIE2 agonist activity of ANGPT2, in comparison with ANGPT1, has been attributed in part to its lower oligomeric forms (43, 59).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,297
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Kim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Self-citation
Cited by
Items 101–167 of 167
Palmer, G. M., Tiran, Z., Zhou, Z., Capozzi, M. E., Park, W., Coletta, C., Pyriochou, A., Kliger, Y., Levy, O., Borukhov, I., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01677.x · Cited by 21
“The coiled-coil domain is involved in ligand homodimerization (Davis et al., 2003), and proper oligomerization/ multimerization is a prerequisite for Tie2 binding and activation (Kim et al., 2005; 2009).”
BackgroundNew soluble angiopoietin analog of Hepta‐ANG1 prevents pathological vascular leakage
Liu, P., Ryczko, M. C., Xie, X., Baardsnes, J., Lord‐Dufour, S., Duroche, Y., Hicks, E. A., Taiyab, A., Sheardown, H. D., Quaggin, S. E., et al. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27580 · Cited by 18
“One of the key distinctions between these two ligands is that Angpt1 self‐clusters into higher‐order oligomers, and this is critical to induce Tie2 activation (Kim et al., 2005; Leppänen et al., 2017).”
BackgroundZhang, Y., Kontos, C. D., Annex, B. H., & Popel, A. S. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-021-00194-6 · Cited by 17
Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis
Shlamkovich, T., Aharon, L., Koslawsky, D., Einav, Y., & Papo, N. (2018) · BMC Biology · doi:10.1186/s12915-018-0557-9 · Cited by 18
Hwang, S.-J., Kim, S. H., Kim, H.-Z., Steinmetz, M. O., Koh, G. Y., & Lee, G. M. (2008) · The Protein Journal · doi:10.1007/s10930-008-9140-5 · Cited by 17
Self-citationKapiainen, E., Kihlström, M. K., Pietilä, R. S., Kaakinen, M., Ronkainen, V., Tu, H., Heikkinen, A., Devarajan, R., Miinalainen, I., Laitakari, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-1904 · Cited by 19
“This was in line with previous results, indicating that designed low-oligomerized forms of ANGPT1 bind less to TIE2 (21).”
ResultSaharinen, P., Jeltsch, M., Santoyo, M. M., Leppänen, V., & Alitalo, K. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_16 · Cited by 21
“Angiopoietins have a unique structure, with a C-terminal TIE2 binding fi brinogen-like domain and N-terminal coiled-coil and superclustering domains that mediate angiopoietin oligomerization into dimers, trimers, and higher-order oligomers [ 105 ] .”
BackgroundTumor Angiogenesis: A Key Target for Cancer Therapy
(2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2 · Cited by 15
The Angiopoietin—Tie System: Common Signaling Pathways for Angiogenesis, Cancer, and Inflammation
Reiss, Y., Scholz, A., & Plate, K. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2907-8_13 · Cited by 18
“Interestingly, Ang2 occurs in the same higher-order multimers as Ang1 but fails to induce receptor activation [41, 42, 44].”
BackgroundBabischkin, J. S., Bonagura, T. W., Udoff, L. C., Vergara, C. O., Johnson, H. W., Atlas, R., Pepe, G. J., & Albrecht, E. D. (2008) · Endocrine · doi:10.1007/s12020-008-9128-0 · Cited by 14
KSHV-infected PEL cell lines exhibit a distinct gene expression profile
Ueda, K., Ito, E., Karayama, M., Ohsaki, E., Nakano, K., & Watanabe, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.122 · Cited by 11
“It has been reported that Ang-2 was expressed well in the KS, in which KSHV-mediated activation of AP-1 and Ets-1 responsive elements seemed to have the functional roles [29,34].”
InfluentialZur, Y., Rosenfeld, L., Bakhman, A. F., Ilic, S., Hayun, H., Shahar, A., Akabayov, B., Kosloff, M., Levaot, N., & Papo, N. (2017) · Biochemical Journal · doi:10.1042/bcj20170276 · Cited by 11
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema
Agard, N. J., Zhang, G., Ridgeway, J., DiCara, D. M., Chu, P. Y., Ohri, R. V., Sanowar, S., Vernes, J.-M., Chi, H. M., Zhang, J., et al. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.10.27 · Cited by 11
Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome
Kreuzer, M., Sollmann, L., Ruben, S., Leifheit‐Nestler, M., Fischer, D., Pape, L., & Haffner, D. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3574-3 · Cited by 10
Bate, N., Lodge, J., & Brindle, N. P. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100888 · Cited by 10
“However, Ang1 exists as a mix of different oligomeric forms, as does Ang2 (22), and this prevents determination of binding kinetics by approaches such as surface plasmon resonance.”
BackgroundGraziano, S., Marchiò, S., Bussolino, F., & Arese, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.045 · Cited by 10
“One hypothesis is that the latter peptide may function by inhibiting Tie2 dimerization [8] while BbcA2 could relieve the receptor from some inhibitory interactions, of which the most plausible are the ones with the strictly related, orphan receptor Tie1 [9], or that with aNRXN, which is shown above.”
Connection of Pericyte–Angiopoietin-Tie-2 System In Diabetic Retinopathy: Friend Or Foe?
Cai, J., Ruan, Q., Chen, Z. J., & Han, S. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.170 · Cited by 10
Ruben, S., Kreuzer, M., Büscher, A. K., Büscher, R., Thumfart, J., Querfeld, U., Staude, H., Ahlenstiel-Grunow, T., Melk, A., Fischer, D., et al. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000489915 · Cited by 10
Platelet Angiopoietin-1 Protects Against Murine Models of Tumor Metastasis
Roweth, H. G., Becker, I. C., Malloy, M. W., Clarke, E. M., Munn, S. A., Kumar, P. L., Aivasovsky-Trotta, I., Tray, K., Schmaier, A. A., & Battinelli, E. M. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321189 · Cited by 9
Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis
Suzuki, T., Loyde, E., Chen, S., Etzrodt, V., Idowu, T. O., Clark, A. J., Saadé, M. C., Flores, B. M., Lu, S., Birrane, G., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci174135 · Cited by 15
“Native ANGPT1 exists as a tetramer and higher-order oligomers, whereas ANGPT2 is less multimerized (32, 33).”
Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2
Issa, E., Moss, A. J., Fischer, M., Kang, M., Ahmed, S., Farah, H., Bate, N., Giakomidi, D., & Brindle, N. P. J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00409 · Cited by 8
Serum levels of angiopoietin-1 in patients with pulmonary hypertension due to mitral stenosis
Karapınar, H., Esen, Ö., Emiroğlu, Y., Akçakoyun, M., Pala, S., Kargın, R., İzgi, A., Kırma, C., & Esen, A. M. (2010) · Heart and Vessels · doi:10.1007/s00380-010-0092-2 · Cited by 7
“The angiopoietin ligands exert their effects through the endothelial-specific tyrosine kinase, Tie2 [5].”
BackgroundPromoting vascular stability through Src inhibition and Tie2 activation: A model-based analysis
Zhang, Y., Kontos, C. D., Annex, B. H., & Popel, A. S. (2025) · iScience · doi:10.1016/j.isci.2025.112625 · Cited by 7
“24 Vascular endothelial protein tyrosine phosphatase (VE-PTP) catalyzes the dephosphorylation of active Tie2 and regulates its activity.”
Shlamkovich, T., Aharon, L., Barton, W. A., & Papo, N. (2017) · Oncotarget · doi:10.18632/oncotarget.16827 · Cited by 6
“, C41S and C54S), produced an Ang1 variant that could not multimerize and was unable to activate Tie2, although it did bind well to Tie2 [3, 9, 45].”
BackgroundInfluentialAnti-angiogenic Targets: Angiopoietin and Angiopoietin-Receptors
Kiss, E. A., & Saharinen, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_4-1 · Cited by 11
“Especially ANGPT1 is further clustered to tetramers, pentamers, or higher oligomeric forms via an N-terminal super-clustering domain (SCD) of angiopoietins (Kim et al. 2005).”
BackgroundAngiopoietins/Tie2 signaling axis and its role in angiogenesis of psoriasis
Li, J., Hou, H., Li, J., & Zhang, K. (2025) · Acta Histochemica · doi:10.1016/j.acthis.2024.152228 · Cited by 4
Monast, C. S., Mehta, N., & Lazzara, M. J. (2013) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-013-0303-x · Cited by 4
Ramkumar, S. (2021) · Cureus · doi:10.7759/cureus.19839 · Cited by 4
“This activates and stimulates a variety of intracellular signaling pathways, including the PI3K/Akt pathway and MAPK pathway [53-55], which increases the EC lifespan.”
BackgroundPeripheral Immune Response Following Traumatic Brain Injury
Hazy, A., Kowalski, E., Groot, N., & Theus, M. H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93597 · Cited by 4
Targeted IgMs agonize ocular targets with extended vitreal exposure
Chen, Y., Paluch, M. T., Zorn, J. A., Rajan, S., Leonard, B. C., Estevez, A., Brady, J. R., Chiu, H. H., Phung, W., Famili, A., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1818436 · Cited by 5
“Clusters of angiopoetin-1 (Ang-1) bind to and oligomerize Tie-2, driving tightening of cell-cell junctions and promoting cell survival.(25) Overexpression of angiopoietin-2 (Ang-2) antagonizes Ang-1 signaling and is thought to drive ocular edema in DME.”
BackgroundPathogenic Mechanisms of Pulmonary Hypertension
Fraidenburg, D. R., & Yuan, J. X. ‐. (2014) · Springer eBooks · doi:10.1007/978-3-642-37078-6_203 · Cited by 4
Hwang, S.-J., Kim, H.-Z., Koh, G. Y., & Lee, G. M. (2007) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-007-9037-1 · Cited by 5
Self-citationAn overview of the molecular and clinical significance of the angiopoietin system in leukemia
Khosravi, S. Z., Ramshe, S. M., Farsani, M. A., Moonesi, M., Marofi, F., & Hagh, M. F. (2023) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2023.2204983 · Cited by 3
“It binds to the ig2-like domain of Tie-2 dimer in a multimeric shape [36] and activates Tie-2 by tyrosine residue auto-phosphorylation in C-terminal.”
BackgroundPul, R., Yildiz, Ö., Morbiducci, F., Skripuletz, T., Schwenkenbecher, P., Stangel, M., Götz, F., Berding, G., Trebst, C., & Donnerstag, F. G. F. (2015) · Disease Markers · doi:10.1155/2015/343818 · Cited by 3
“Ang-2 forms multimeric structures composed of monomers of 55 kDa and the native form is mainly present as disulfide-linked dimers, but variable oligomeric forms may exist as well [19].”
BackgroundVEGF and Notch Signaling in Angiogenesis
Teodorczyk, M., Stanković, N. D., Bicker, F., & Schmidt, M. H. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2907-8_1 · Cited by 5
Angiopoietins and Tie Receptors
Saharinen, P., Eklund, L., & Alitalo, K. K. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_10 · Cited by 4
“However, in their native forms Ang1 and Ang2 exist as oligomers with 2 or more receptor binding sites, and at least Ang1 is further clustered into multimers [22, 23, 27].”
BackgroundMethodLa agroexportación ante la nueva distribución alimentaria
Obrador, J. M., & Planells, J. M. (2002) · Dialnet (Universidad de la Rioja) · Cited by 7
Urinary trypsin inhibitor exerts multifaceted regulation of angiopoietin 2 in septic cardiomyopathy
Lu, Y.-N., Wang, X., Xu, B., Zheng, Y., Zhang, X., Liu, Y., Wang, T.-Y., & Yu, F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177944 · Cited by 2
Angiopoietin-1 for Myocardial Angiogenesis
Lai, V. K., Zeeshan, M., Ashraf, M., & Husnain, K. (2011) · InTech eBooks · doi:10.5772/20028 · Cited by 2
“Similarly, structural characteristics and distinguishable interaction with other molecules in the extracellular environment of the ligands may also essentially contribute to their counteractive properties (Kim et al. 2005).”
The Significance of Angiopoietin Valency in Vascular Health and Disease
Zhao, Y. T., Ehnes, D. D., Mathieu, J., & Ruohola‐Baker, H. (2026) · Cells · doi:10.3390/cells15090820 · Cited by 3
“Both ligands form higher-order multimers via disulfide bonds between cysteine residues on the SCD and CCD, but Ang 1 shows a higher propensity for oligomerization [59].”
InfluentialKrzysztof, D., Sapilak, B. J., Steciwko, A., Magdalena, G., Tomasz, B., & Filipczyk−Cisarż, E. (2011) · Family Medicine & Primary Care Review · Cited by 1
Direct contribution of angiogenic factors to neurodevelopment: a focus on angiopoietins
Luck, R., Karakatsani, A., & de Almodóvar, C. R. (2020) · e-Neuroforum · doi:10.1515/nf-2020-0025 · Cited by 2
Korpela, E., Yohan, D., Chin, L. C. L., Kim, A., Huang, X., Sade, S., Slyke, P. V., Dumont, D., & Liu, S. K. (2021) · doi:10.32920/14639919 · Cited by 1
Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling
Sipilä, T., Ponna, S. K., Venkatesha Murthy, A., Pink, A., Enkavi, G., Bohra, S. K., Lewna, K., Ganesh, K., Liu, Q., Korhonen, M., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci190552
“Thrombin stimulation disrupted the continuous CDH5 junctional pattern and reduced dimers, contributing to weaker TIE2 activation (43).”
Angiopoietin-2 in der Intensivmedizin: Vom Mediator des Kapillarlecks zum prognostischen Biomarker
Kümpers, P., & David, S. (2009) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-009-0044-1
Protein Kinase Structure, Function, and Regulation
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch2
Regulation of EGF receptor dynamics by protein tyrosine phosphatases
Monast, C. S. (2013) · ScholarlyCommons (University of Pennsylvania)
Angiopoietin-1 and -2 in Infectious Diseases associated with Endothelial Cell Dysfunction
Page, A. V., & Liles, W. C. (2012) · TSpace (University of Toronto)
The Role of Angiopoietin-2 in Signaling Through the Endothelial Receptor Tyrosine Kinase Tie1
Otvos, B. I. (2010) · DukeSpace (Duke University)
Backhaus, R. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4524
The Role of Tie1 Threonine Phosphorylation in a Novel Angiogenesis Regulatory Pathway
Reinardy, J. L. (2015) · DukeSpace (Duke University)
The Tie2 RTK : regulation and downstream signaling.
Sturk, C. (2010) · TSpace (University of Toronto)
Characterization of Tie2 signalling during acute inflammation
Smith, T. L. (2018) · TSpace (University of Toronto)
Hakanpää, L. (2020) · Helda - University of Helsinki Institutional Repository
Higgins, S. J. (2014) · TSpace (University of Toronto)
Examining the prostate stroma and vasculature : importance and potential as targets for therapy
Johansson, A. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Korpela, E., Yohan, D., Chin, L. C. L., Kim, A., Huang, X., Sade, S., Slyke, P. V., Dumont, D., & Liu, S. K. (2021) · doi:10.32920/14639919.v1
Kapiainen, E., Kihlström, M. K., Pietilä, R. S., Kaakinen, M., Ronkainen, V., Tu, H., Heikkinen, A., Devarajan, R., Miinalainen, I., Laitakari, A., et al. (2023) · doi:10.1158/0008-5472.c.6512358.v1
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2023) · doi:10.1158/0008-5472.c.6500714
Angiopoietin-2 adsorption attempt with the cytokine adsorber cytosorb in critically ill patients
Graf, H., Gräfe, C., Paal, M., Habler, K., Ewert, A., Wilfert, W., Liebchen, U., Bender, M., Hackner, D., & Scharf, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-21215-y
Tie1 et la transition endothélio-mésenchymateuse
Garcia, J. (2013) · theses.fr (ABES) · doi:10.70675/063d32edz5c5cz44e7zb912z0fa2bc96180b
Sénescence cellulaire et nouvelles approches thérapeutiques de l'hypertension artérielle pulmonaire
Mouraret, N. (2013) · theses.fr (ABES) · doi:10.70675/b2ae892dzafc0z4b55z9d55zb8908a6a07c7
Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse
Cossutta, M. (2017) · theses.fr (ABES) · doi:10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda · Cited by 1
Liabotis, A. (2018) · theses.fr (ABES) · doi:10.70675/52bcdc87z9aedz40abz9459z9019f91b56fe
Integrin-independent Tie2 activation using de novo designed proteinsPreprint
McCurdy, C., Zhao, Y. T., Kumar, S., Coventry, B., Pink, A., Fu, Y., Bohn, P., Zhu, S., Goreshnik, I., Wang, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.718274
Self-citationVollmer, T. R., Dolan, K., Xiang, C., Banks, A., Cooney, E. M., Heyder, J., King, C. C., Vrouvlianis, J., Gujar, A. N., Kirkpatrick, N. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.27.751872
Engineering Novel Angiopoietin Receptor Ligands
Moss, A. (2011) · Figshare
Metadata
- Authors
- Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- Paul Scherrer Institute (CH)
- University of Basel (CH)
- Wellcome Centre for Cell-Matrix Research (GB)
- Corresponding author
- Koh, Gou Young
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 280
- Issue
- 20
- Pages
- 20126-20131
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2016078651
- Cited by
- 170
- References
- 32
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 8 · 2017: 15 · 2016: 3 · 2015: 9 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5641 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Wellcome Trust
- Korea Science and Engineering Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- angiopoietin-1, angiopoietin-2, Tie2 receptor, receptor oligomerization, receptor multimerization, disulfide bonds, cysteine residues, receptor activation, receptor binding, angiogenesis, structure-function relationship, protein aggregation
- MeSH terms
- Animals, Cell Line, Cysteine, Enzyme Activation, Humans, Microscopy, Electron, Phosphorylation, Protein Binding, Recombinant Proteins, Genetic Variation, Protein Structure, Quaternary, 3T3-L1 Cells, Angiopoietin-1, Angiopoietin-2, Receptor, TIE-2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.